$1.18
0.05[4.42%]
At close: Apr 26
$1.18
0[0.00%]
After Hours: 7:59PM EDT
X4 Pharmaceuticals
(NASDAQ:XFOR)X4 Pharmaceuticals Stock (NASDAQ:XFOR), Insider Trading Activity
X4 Pharmaceuticals: Insider buying and selling updated today.
Insider Shares Owned
3.095M
Insider Percentage Owned
1.84%
Institutional Shares Held
30.006M
Institutional Percentage Held
17.9%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -14.235K | $0.88 | -$12.55K | SELL | -5.73% | 234.301K | Mar 11 | View |
| Mar 11, 2024 | Paula Ragan | PRESIDENT AND CEO | -49.678K | $0.88 | -$43.86K | SELL | -6.10% | 765.068K | Mar 11 | View |
| Mar 11, 2024 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -52.5K | $0.88 | -$46.35K | SELL | -100.00% | 0 | Mar 11 | View |
| Mar 11, 2024 | Mary DiBiase | CHIEF OPERATING OFFICER | -15.409K | $0.88 | -$13.59K | SELL | -5.02% | 291.752K | Mar 11 | View |
| Feb 12, 2024 | Mary DiBiase | CHIEF OPERATING OFFICER | -3.683K | $1.01 | -$3.71K | SELL | -1.18% | 307.161K | Feb 12 | View |
| Feb 12, 2024 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -787 | $1.01 | -$792.67 | SELL | -0.32% | 248.536K | Feb 12 | View |
| Feb 12, 2024 | Paula Ragan | PRESIDENT AND CEO | -21.695K | $1.01 | -$21.89K | SELL | -2.59% | 814.746K | Feb 12 | View |
| Feb 12, 2024 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -27.721K | $1.01 | -$27.97K | SELL | -34.56% | 52.5K | Feb 12 | View |
| Nov 03, 2023 | Paula Ragan | PRESIDENT AND CEO | -239.437K | $0.76 | -$181.57K | SELL | -22.26% | 836.441K | Nov 01 - Nov 03 | View |
| Nov 03, 2023 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -230.645K | $0.73 | -$168.37K | SELL | -74.19% | 80.221K | Nov 01 | View |
| Nov 03, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -67.695K | $0.73 | -$49.42K | SELL | -17.88% | 310.844K | Nov 01 | View |
| Nov 03, 2023 | Mark Baldry | CHIEF COMMERCIAL OFFICER | -10.257K | $0.73 | -$7.49K | SELL | -29.35% | 24.69K | Nov 01 | View |
| Nov 03, 2023 | Arthur Taveras | CHIEF SCIENTIFIC OFFICER | -67.695K | $0.73 | -$49.42K | SELL | -21.35% | 249.323K | Nov 01 | View |
| Sep 12, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -2.642K | $1.25 | -$3.30K | SELL | -1.76% | 147.894K | Sep 08 | View |
| Aug 22, 2023 | MICHAEL WYZGA | DIRECTOR | 25K | $1.20 | $29.88K | BUY | 48.39% | 76.667K | Aug 18 | View |
| Aug 11, 2023 | Murray Stewart | INTERIM CHIEF MEDICAL OFFICER | 139.837K | $1.06 | -$137.86K | GRANT | 2097.45% | 146.504K | Aug 09 - Aug 10 | View |
| Jul 05, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -464 | $1.89 | -$876.96 | SELL | -0.31% | 150.536K | Jun 30 | View |
| Jul 05, 2023 | Adam Mostafa | CHIEF FINANCIAL OFFICER | -2.641K | $1.89 | -$4.99K | SELL | -3.19% | 80.221K | Jun 30 | View |
| Jun 26, 2023 | Mary DiBiase | CHIEF OPERATING OFFICER | -857 | $1.93 | -$1.65K | SELL | -0.56% | 151K | Jun 23 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
XFOR Insider Trading News
No news found